Patient attitudes towards chemotherapy as assessed by patient versus physician: A prospective observational study in advanced non-small cell lung cancer

Lung Cancer

Volumn 56, Issue 3, 2007, Pages 433-443

  Chu, Da Tong ^a   Kim, Sang We ^b   Kuo, Han Pin ^c   Ozacar, Rifat ^d   Salajka, Frantisek ^e   Krishnamurthy, S ^f   Damyanov, Danail ^g   Altug, Sedat ^h   Reece, William H H ⁱ   Wang, Li ^j  

^a CANCER HOSPITAL   (China)

^b Asan Medical Center   (South Korea)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d Training Hospital   (Turkey)

^e CHARLES UNIVERSITY   (Czech Republic)

^f KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^g National Oncology Center Bulgaria   (Bulgaria)

^h Eli Lilly   (Turkey)

ⁱ Intercontinental Information Sciences   (Australia)

^j Eli Lilly Asia Inc   (China)

more..

Author keywords

Attitude; Chemotherapy; Gemcitabine; Need; Non small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DATA ANALYSIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF EVALUATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ATTITUDE TO HEALTH; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RIBONUCLEOTIDE REDUCTASES;

EID: 34247876021     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.01.028     Document Type: Article

References (23)

1. Hoffman P.C., Mauer A.M., and Vokes E.E. Lung cancer. Lancet 355 (2000) 479-485
2. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311 (1995) 899-909
3. Schiller J.H., Harrington D., Belani C.P., et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 346 (2002) 92-98
4. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Version 2, 2005.
5. Yardley S.J., Davis C.L., and Sheldon F. Receiving a diagnosis of lung cancer: patients' interpretations, perceptions and perspectives. Palliat Med 15 (2001) 379-386
6. Koedoot C.G., de Haan R.J., Stiggelbout A.M., et al. A prospective study explaining patients' treatment preference and choice. Palliative chemotherapy or best supportive care?. Br J Cancer 89 (2003) 219-226
7. Jennens R.R., de Boer R., and Irving L. Differences of opinion: a survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer. Chest 126 (2004) 1985-1993
8. Stephens R.J., Hopwood P., Girling D.J., and Machin D. Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?. Qual Life Res 6 (1997) 225-236
9. Sneeuw K.C., Aaronson N.K., Sprangers M.A., Detmar S.B., Wever L.D., and Schornagel J.H. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51 (1998) 617-631
10. Sneeuw K.C., Aaronson N.K., Sprangers M.A., Detmar S.B., Wever L.D., and Schornagel J.H. Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses. Br J Cancer 81 (1999) 87-94
11. Lampic C., and Sjoden P.O. Patient and staff perceptions of cancer patients' psychological concerns and needs. Acta Oncol 39 (2000) 9-22
12. Altman D.G. Practical statistics for medical research. 1st ed. (1991), Chapman & Hall, London
13. Voogt E., van der Heide A., Rietjens J.A., et al. Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol 23 (2005) 2012-2019
14. Hirose T., Horichi N., Ohmori T., et al. Patients preferences in chemotherapy for advanced non-small-cell lung cancer. Intern Med 44 (2005) 107-113
15. Slevin M.L., Stubbs L., Plant H.J., et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 300 (1990) 1458-1460
16. Silvestri G., Pritchard R., and Welch H.G. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 317 (1998) 771-775
17. Weeks J.C., Cook E.F., O'Day S.J., et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279 (1998) 1709-1714
18. Brundage M.D., Feldman-Stewart D., Cosby R., et al. Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns 45 (2001) 149-157
19. Balmer C.E., Thomas P., and Osborne R.J. Who wants second-line, palliative chemotherapy?. Psychooncology 10 (2001) 410-418
20. Grunfeld E.A., Maher E.J., Browne S., et al. Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy. J Clin Oncol 24 (2006) 1090-1098
21. Solomon M.J., Pager C.K., Keshava A., et al. What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer. Dis Colon Rectum 46 (2003) 1351-1357
22. Penson R.T., Dignan F., Seiden M.V., et al. Attitudes to chemotherapy in patients with ovarian cancer. Gynecol Oncol 94 (2004) 427-435
23. Perez E.A. Perceptions of prognosis, treatment, and treatment impact on prognosis in non small cell lung cancer. Chest 114 (1998) 593-604